Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia.

COVID-19 Colombia SARS SARS-CoV-2 coronavirus coronavirus disease genome sequencing phylogenomics respiratory infections severe acute respiratory syndrome coronavirus 2 viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 21 11 2020
pubmed: 22 11 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical samples we collected, along with another 79 genome sequences available from Colombia. We investigated the emergence and importation routes for SARS-CoV-2 into Colombia by using epidemiologic, historical air travel, and phylogenetic observations. Our study provides evidence of multiple introductions, mostly from Europe, and documents >12 lineages. Phylogenetic findings validate the lineage diversity, support multiple importation events, and demonstrate the evolutionary relationship of epidemiologically linked transmission chains. Our results reconstruct the early evolutionary history of SARS-CoV-2 in Colombia and highlight the advantages of genome sequencing to complement COVID-19 outbreak investigations.

Identifiants

pubmed: 33219646
doi: 10.3201/eid2612.202969
pmc: PMC7706936
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2854-2862

Subventions

Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024855/1
Pays : United Kingdom

Références

J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
BMC Med. 2020 May 7;18(1):124
pubmed: 32375776
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
J Med Virol. 2020 Sep;92(9):1562-1566
pubmed: 32222995
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Nat Microbiol. 2019 Jan;4(1):10-19
pubmed: 30546099
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Int J Equity Health. 2020 Jun 8;19(1):91
pubmed: 32513261
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
Lancet Public Health. 2020 May;5(5):e261-e270
pubmed: 32220655
Virus Evol. 2020 Apr 10;6(1):veaa027
pubmed: 32296544
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Travel Med. 2020 May 18;27(3):
pubmed: 32211799
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Lancet Digit Health. 2020 Apr;2(4):e201-e208
pubmed: 32309796
Syst Biol. 2016 Jan;65(1):82-97
pubmed: 26424727
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Am J Trop Med Hyg. 2020 Jun;102(6):1210-1213
pubmed: 32342849
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Science. 2020 Apr 24;368(6489):395-400
pubmed: 32144116
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH